Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Home/The Filing Wire/OSR Health, Inc./ 10-Q

Quarterly Report · 10-Q

OSR Health, Inc.

Quarterly Report

Filed Aug 14, 2026Accepted Aug 14, 2026, 3:08 PM EDTCIK 1840425Accession 0001213900-26-089904
View company →Permanent SEC source ↗
Share

Company context

OSR Health, Inc. (NASDAQ:OSRH) is a global healthcare holding company dedicated to advancing biomedical innovations in health and wellness. Through its subsidiaries, OSR Health engages in immuno-oncology, regenerative biologics, and medical device technologies to improve health outcomes worldwide. Learn more at www.osr-health.com

Current securities

OSRHOTC · EQUITY · CurrentOSRHWOTC · WARRANT · Current
Historical securities (5)
BLACNASDAQ · EQUITY · Historical · closed Feb 14, 2025BLACUNASDAQ · UNIT · Historical · closed Feb 14, 2025BLACWOTC · WARRANT · Historical · closed Feb 14, 2025OSRHNASDAQ · EQUITY · Historical · closed Aug 24, 2026OSRHWNASDAQ · WARRANT · Historical · closed Aug 24, 2026

Recent company filings

  1. Other EventsAug 28, 2026
  2. Other EventsAug 25, 2026
  3. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing · Regulation FD DisclosureAug 19, 2026
  4. SCHEDULE 13G/A filingAug 17, 2026
  5. Submission of Matters to a Vote of Security HoldersAug 10, 2026

As-filed source

Primary evidence
As filedOpen full document ↗